These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 66615)

  • 1. Melanocyte-stimulating-hormone levels in doxorubicin-induced hyperpigmentation.
    Kew MC; Mzamane D; Smith AG; Shuster S
    Lancet; 1977 Apr; 1(8015):811. PubMed ID: 66615
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma ACTH and melanocyte-stimulating hormone in nail pigmentation.
    Arakawa S; Takamatsu T; Imashuku S; Kusunoki T
    Arch Dis Child; 1978 Mar; 53(3):249-50. PubMed ID: 206211
    [No Abstract]   [Full Text] [Related]  

  • 3. Chloasma, oral contraceptives, and plasma immunoreactive beta-melanocyte-stimulating hormone.
    Smith AG; Shuster S; Thody AJ; Peberdy M
    J Invest Dermatol; 1977 Apr; 68(4):169-70. PubMed ID: 845449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma immunoreactive beta-melanocyte-stimulating hormone in chronic liver disease and fulminant hepatic failure.
    Smith AG; Shuster S; Bomford A; Williams R
    J Invest Dermatol; 1978 Jun; 70(6):326-7. PubMed ID: 649979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The pituitary hormones (beta MSH-ACTH) in hyperpigmented hepatic cirrhosis. Apropos of 10 cases].
    Valla D; Cunci O; Girard F; Thomas M
    Med Chir Dig; 1976; 5(7):329-34. PubMed ID: 190485
    [No Abstract]   [Full Text] [Related]  

  • 6. [Plasma ACTH and beta-MSH in normal subjects and in pituitary-adrenal pathology and in non-endocrine pigmentation disorders].
    Usategui Echevarría R; Oliver C; Laffite JM; Jimeno Carruez A; Ortíz Manchado O; Vague J
    Rev Clin Esp; 1975 Oct; 139(2):163-9. PubMed ID: 172985
    [No Abstract]   [Full Text] [Related]  

  • 7. Blue-gray pigmentation in a patient receiving doxorubicin.
    Konohana A
    J Dermatol; 1992 Apr; 19(4):250-2. PubMed ID: 1318885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoreactive beta-melanocyte-stimulating hormone and melanin pigmentation in systemic sclerosis.
    Smith AG; Holti GS; Shuster S
    Br Med J; 1976 Sep; 2(6038):733-4. PubMed ID: 974574
    [No Abstract]   [Full Text] [Related]  

  • 9. Hyperpigmentation due solely to increased plasma beta-melanotropin.
    Sawin CT; Abe K; Orth DN
    Arch Intern Med; 1970 Apr; 125(4):708-10. PubMed ID: 4314528
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter: Hyperpigmentation of nails from doxorubicin.
    Pratt CB; Shanks EC
    JAMA; 1974 Apr; 228(4):460. PubMed ID: 4406195
    [No Abstract]   [Full Text] [Related]  

  • 11. Doxorubicin induced hyperpigmentation.
    Kumar L; Kochupillai V
    N Z Med J; 1990 Apr; 103(887):165. PubMed ID: 2342686
    [No Abstract]   [Full Text] [Related]  

  • 12. Doxorubicin and hyperpigmentation.
    Alagaratnam TT; Choi TK; Ong GB
    Aust N Z J Surg; 1982 Oct; 52(5):531-3. PubMed ID: 6959604
    [No Abstract]   [Full Text] [Related]  

  • 13. Doxorubicin-associated hyperpigmentation.
    Curran CF
    N Z Med J; 1990 Oct; 103(900):517. PubMed ID: 2234654
    [No Abstract]   [Full Text] [Related]  

  • 14. [Melanin thesaurismosis with special reference to melanocyte stimulating hormone (MSH) secretion anomalies].
    Abe K
    Nihon Rinsho; 1972 Nov; 30(11):2243-8. PubMed ID: 4346765
    [No Abstract]   [Full Text] [Related]  

  • 15. [Nail hyperpigmentation as a secondary effect of doxorubicin].
    Sanz Ortiz J; Méndez Batán MA; Fariñas Alvarez C; Gutiérrez del Río C
    Med Clin (Barc); 1982 Jun; 79(1):49-50. PubMed ID: 7121110
    [No Abstract]   [Full Text] [Related]  

  • 16. Nail hyperpigmentation secondary to therapy with doxorubicin.
    Giacobetti R; Esterly NB; Morgan ER
    Am J Dis Child; 1981 Apr; 135(4):317-8. PubMed ID: 7211789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma immunoreactive beta-melanocyte-stimulating hormone and skin pigmentation in chronic renal failure.
    Smith AG; Shuster S; Comaish JS; Plummer NA; Thody AJ; Alvarez-Ude F; Kerr DN
    Br Med J; 1975 Mar; 1(5959):658-9. PubMed ID: 1125653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letter: Adriamycin and longitudinal pigmented banding of fingernails.
    Priestman TJ; James KW
    Lancet; 1975 Jun; 1(7920):1337-8. PubMed ID: 49535
    [No Abstract]   [Full Text] [Related]  

  • 19. Normal and abnormal regulation of beta-msh in man.
    Abe K; Nicholson WE; Liddle GW; Orth DN; Island DP
    J Clin Invest; 1969 Aug; 48(8):1580-5. PubMed ID: 4307702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pigmentation with doxorubicin therapy.
    Orr LE; McKernan JF
    Arch Dermatol; 1980 Mar; 116(3):273. PubMed ID: 6245620
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.